We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Long-Term ECG Monitoring Helps Diagnose Atrial Fibrillation

By HospiMedica International staff writers
Posted on 12 Apr 2012
A wireless ambulatory monitoring system offers electrophysiologists and cardiologists the advantages of both a Holter electrocardiogram (ECG) and cardiac event monitor in one device.

The TruVue ECG Monitoring System is intended for the diagnosis and management of atrial fibrillation (AF) and other complex cardiac arrhythmia, as well as serving as a platform for pharmaceutical and medical device companies to assess the cardiovascular safety and efficacy associated with new drugs and devices. More...
The system’s diagnostic benefits include the ability to record and wirelessly transmit every heartbeat for up to 30 days; perform advanced arrhythmia analysis; and to provide immediate online access to all transmitted ECG data.

The patented technology employs cellular communication to transmit recordings of every heartbeat to secure servers, where proprietary algorithms analyze the incoming data for changes in morphology, rate, or rhythm. Patients can also initiate alerts when symptoms are experienced. Certified cardiac technicians validate the findings, post reports in real time, and alert physicians based on cardiac events or notification criteria. At any time, physicians can access information online, including any portion of the recorded ECG monitoring and trend reports detailing 24-hour heart rate and rhythm abnormalities, including AF. The TruVue ECG Monitoring System is a product of Biomedical Systems (St. Louis, MO, USA).

“TruVue expedites the diagnoses of patients who may have cardiac arrhythmia, including atrial fibrillation, by delivering the most comprehensive long-term view of the heart rhythm,” said Jim Ott, president of the cardiology division at Biomedical Systems. “With TruVue, we provide physicians with the unique ability to review every heartbeat for up to 30 days, combining both algorithm-triggered ECG-recordings and episodes recorded by patients, and immediately access information online without working through support staff.”

A Holter monitor (named for physicist Dr. Norman J. Holter, who invented telemetric cardiac monitoring in 1949) is a portable device for continuously monitoring various electrical activity of the cardiovascular system or monitoring brain activity for at least 24 hours (often for two weeks at a time). The extended recording period is useful for observing occasional cardiac arrhythmias or epileptic events, which would be difficult to identify in a shorter period of time. For patients having more transient symptoms, a cardiac event monitor, which can be worn for a month or more, can be used.

Related Links:
Biomedical Systems


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.